{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:56:06Z","timestamp":1792526166206,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["ERAMET GA101137141"],"award-info":[{"award-number":["ERAMET GA101137141"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10928-025-10018-3","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:02:52Z","timestamp":1772478172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Model informed assessment of QT prolongation during drug development: a five-year retrospective analysis of EMA scientific advices"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7323-7176","authenticated-orcid":false,"given":"Happy Phanio","family":"Djokoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2107-1804","authenticated-orcid":false,"given":"Jean-Michel","family":"Dogn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-8870","authenticated-orcid":false,"given":"Flora T.","family":"Musuamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"10018_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061324","author":"RM Lester","year":"2019","unstructured":"Lester RM et al (2019) Qt assessment in early drug development: the long and the short of it. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20061324","journal-title":"Int J Mol Sci"},{"key":"10018_CR2","unstructured":"EMA (2005) ICH E14 Clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs - Scientific guideline. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-14-clinical-evaluation-qtqts-interval-prolongation-and-proarrhythmic-potential-non-antiarrhythmic-drugs-step-5_en.pdf"},{"key":"10018_CR3","unstructured":"EMA (2015) ICH E14 Guideline the clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Questions & answers (R3). https:\/\/database.ich.org\/sites\/default\/files\/E14_Q%26As_R3_Q%26As.pdf"},{"key":"10018_CR4","unstructured":"Administration USFD (2024) Streamlining analysis of ion channel in vitro assays data to support clinical cardiac safety decision-making. https:\/\/www.fda.gov\/drugs\/regulatory-science-action\/streamlining-analysis-ion-channel-in-vitro-assays-data-support-clinical-cardiac-safety-decision-making?utm_source=chatgpt.com"},{"issue":"3","key":"10018_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10928-017-9558-5","volume":"45","author":"C Garnett","year":"2018","unstructured":"Garnett C et al (2018) Scientific white paper on concentration-QTc modeling. J Pharmacokinet Pharmacodyn 45(3):383\u2013397. https:\/\/doi.org\/10.1007\/s10928-017-9558-5","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10018_CR6","unstructured":"EMA (2024) Scientific Explorer - Frequently Asked Questions (FAQs). https:\/\/www.ema.europa.eu\/system\/files\/documents\/other\/scientific-explorer-frequently-asked-questions_en.pdf"},{"key":"10018_CR7","unstructured":"EMA (2011) ICH guideline S6 (R1) \u2013 preclinical safety evaluation of biotechnology-derived pharmaceuticals T. E. Union. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-s6r1-preclinical-safety-evaluation-biotechnology-derived-pharmaceuticals-step-5_en.pdf"},{"key":"10018_CR8","unstructured":"ICH (2005) ICH Topic S 7 B The nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-s-7-b-nonclinical-evaluation-potential-delayed-ventricular-repolarization-qt-interval-prolongation-human-pharmaceuticals-step-5_en.pdf"},{"key":"10018_CR9","unstructured":"EMA (2010) ICH guideline S9 on nonclinical evaluation for anticancer pharmaceuticals. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-s9-non-clinical-evaluation-anticancer-pharmaceuticals-step-5_en.pdf"},{"key":"10018_CR10","unstructured":"EMA (2018) Guideline on the non-clinical requirements for radiopharmaceuticals. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-non-clinical-requirements-radiopharmaceuticals-first-version_en.pdf"},{"key":"10018_CR11","unstructured":"EMA (2025) European medicines agency guidance for applicants seeking scientific advice and protocol assistance. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/european-medicines-agency-guidance-applicants-seeking-scientific-advice-protocol-assistance_en.pdf"},{"key":"10018_CR12","doi-asserted-by":"publisher","unstructured":"Celliere G et al (2025) Beyond the linear model in concentration-QT analysis. J Pharmacokinet Pharmacodyn 52(3):31. https:\/\/doi.org\/10.1007\/s10928-025-09975-6","DOI":"10.1007\/s10928-025-09975-6"},{"issue":"10","key":"10018_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/jcph.1880","volume":"61","author":"B Darpo","year":"2021","unstructured":"Darpo B, Ferber G (2021) The new S7B\/E14 question and answer draft guidance for industry: contents and commentary. J Clin Pharmacol 61(10):1261\u20131273. https:\/\/doi.org\/10.1002\/jcph.1880","journal-title":"J Clin Pharmacol"},{"key":"10018_CR14","doi-asserted-by":"publisher","unstructured":"Darpo B, Leishman DJ (2023) The new S7B\/E14 Q&a document provides additional opportunities to replace the thorough QT study. J Clin Pharmacol 63(11):1256\u20131274. https:\/\/doi.org\/10.1002\/jcph.2309","DOI":"10.1002\/jcph.2309"},{"issue":"2","key":"10018_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/psp4.12161","volume":"6","author":"TH Nguyen","year":"2017","unstructured":"Nguyen TH et al (2017) Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol 6(2):87\u2013109. https:\/\/doi.org\/10.1002\/psp4.12161","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10018_CR16","doi-asserted-by":"publisher","unstructured":"Aguado-Sierra J et al (2024) Virtual clinical QT exposure-response studies - a translational computational approach. J Pharmacol Toxicol Methods 126:107498. https:\/\/doi.org\/10.1016\/j.vascn.2024.107498","DOI":"10.1016\/j.vascn.2024.107498"},{"key":"10018_CR17","doi-asserted-by":"publisher","unstructured":"Sheng J, Zhang T (2025) Advancing drug development with \u201cfit-for-purpose\u201d modeling informed approaches. J Pharmacokinet Pharmacodyn 52(5):52. https:\/\/doi.org\/10.1007\/s10928-025-09995-2","DOI":"10.1007\/s10928-025-09995-2"},{"key":"10018_CR18","doi-asserted-by":"publisher","unstructured":"Kijima S et al (2022) Activity and perspective on quantitative modeling and simulation in Japan: update from the Pharmaceuticals and Medical Devices Agency. CPT Pharmacometrics Syst Pharmacol 11(12):1552\u20131555. https:\/\/doi.org\/10.1002\/psp4.12868","DOI":"10.1002\/psp4.12868"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-025-10018-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-025-10018-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-025-10018-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:44:29Z","timestamp":1777578269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-025-10018-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10018"],"URL":"https:\/\/doi.org\/10.1007\/s10928-025-10018-3","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}